Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction-Outcomes at two years.

MLA

Omerovic, Elmir, et al. “Bivalirudin versus Heparin in ST and Non-ST-Segment Elevation Myocardial Infarction-Outcomes at Two Years.” Cardiovascular Revascularization Medicine : Including Molecular Interventions, vol. 66, Sept. 2024, pp. 43–50. EBSCOhost, https://doi.org/10.1016/j.carrev.2024.03.025.

APA

Omerovic, E., James, S., Råmundal, T., Fröbert, O., Linder, R., Danielewicz, M., Hamid, M., Pagonis, C., Henareh, L., Wagner, H., Stewart, J., Jensen, J., Lindros, P., Robertsson, L., Wikström, H., Ulvenstam, A., Bhiladval, P., Tödt, T., Ioanes, D., … Erlinge, D. (2024). Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction-Outcomes at two years. Cardiovascular Revascularization Medicine : Including Molecular Interventions, 66, 43–50. https://doi.org/10.1016/j.carrev.2024.03.025

Chicago

Omerovic, Elmir, Stefan James, Truls Råmundal, Ole Fröbert, Rikard Linder, Mikael Danielewicz, Mehmet Hamid, et al. 2024. “Bivalirudin versus Heparin in ST and Non-ST-Segment Elevation Myocardial Infarction-Outcomes at Two Years.” Cardiovascular Revascularization Medicine : Including Molecular Interventions 66 (September): 43–50. doi:10.1016/j.carrev.2024.03.025.